153 related articles for article (PubMed ID: 35431230)
1. Circulating microRNAs as molecular biomarkers for lung adenocarcinoma.
Robinson I; Bertsch A; Leithner K; Stiegler P; Olschewski H; Hrzenjak A
Cancer Biomark; 2022; 34(4):591-606. PubMed ID: 35431230
[TBL] [Abstract][Full Text] [Related]
2. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
3. A combination of four serum miRNAs for screening of lung adenocarcinoma.
Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y
Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809
[TBL] [Abstract][Full Text] [Related]
4. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
5.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of aberrantly expressed microRNA profiles reveals potential biomarkers of human lung adenocarcinoma progression.
Sui J; Yang RS; Xu SY; Zhang YQ; Li CY; Yang S; Yin LH; Pu YP; Liang GY
Oncol Rep; 2017 Oct; 38(4):2453-2463. PubMed ID: 28791371
[TBL] [Abstract][Full Text] [Related]
7. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
Yu N; Yong S; Kim HK; Choi YL; Jung Y; Kim D; Seo J; Lee YE; Baek D; Lee J; Lee S; Lee JE; Kim J; Kim J; Lee S
Mol Oncol; 2019 Jun; 13(6):1356-1368. PubMed ID: 30913346
[TBL] [Abstract][Full Text] [Related]
9. Biomarker of Pulmonary Inflammatory Response in LUAD: miR-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.
Yang E; Hong Y; Xuan C; Xu J; Ding Q; Zhao S; Ye H; Fan X; Jiang Z; Zhang S; Ding X
Protein Pept Lett; 2023; 30(10):877-890. PubMed ID: 38093594
[TBL] [Abstract][Full Text] [Related]
10. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
11. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
Li T; Liu H; Dong C; Lyu J
Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Dual Strands of
Sanada H; Seki N; Mizuno K; Misono S; Uchida A; Yamada Y; Moriya S; Kikkawa N; Machida K; Kumamoto T; Suetsugu T; Inoue H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514295
[TBL] [Abstract][Full Text] [Related]
13. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
Yerukala Sathipati S; Ho SY
Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
16. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
17. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
[TBL] [Abstract][Full Text] [Related]
18. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.
Misono S; Seki N; Mizuno K; Yamada Y; Uchida A; Arai T; Kumamoto T; Sanada H; Suetsugu T; Inoue H
J Hum Genet; 2018 Oct; 63(10):1015-1028. PubMed ID: 30082847
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma.
Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S
Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways.
Reis PP; Drigo SA; Carvalho RF; Lopez Lapa RM; Felix TF; Patel D; Cheng D; Pintilie M; Liu G; Tsao MS
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
